Reply: a new look at the pathogenesis of Parkinson’s disease
- 1 May 2000
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 21 (5), 165
- https://doi.org/10.1016/s0165-6147(00)01470-x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson diseaseNature Medicine, 1999
- Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposureAnnals of Neurology, 1999
- FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces,In Vitro,Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial CellsJournal of Neuroscience, 1999
- Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.Proceedings of the National Academy of Sciences, 1996
- Nitric oxide synthase and neuronal vulnerability in parkinson's diseaseNeuroscience, 1996
- Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brainsNeurology, 1988